ATE425459T1 - Der effekt von steroiden auf ndma-rezeptoren beruht auf der zusammensetzung der untereinheiten - Google Patents

Der effekt von steroiden auf ndma-rezeptoren beruht auf der zusammensetzung der untereinheiten

Info

Publication number
ATE425459T1
ATE425459T1 AT00959706T AT00959706T ATE425459T1 AT E425459 T1 ATE425459 T1 AT E425459T1 AT 00959706 T AT00959706 T AT 00959706T AT 00959706 T AT00959706 T AT 00959706T AT E425459 T1 ATE425459 T1 AT E425459T1
Authority
AT
Austria
Prior art keywords
subunit
receptors
nmda
modulator
subunits
Prior art date
Application number
AT00959706T
Other languages
English (en)
Inventor
David H Farb
Shelley Russek
Ming-Kuei Jang
Terrell Gibbs
Nader Yaghoubi
Original Assignee
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22540293&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE425459(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Boston filed Critical Univ Boston
Application granted granted Critical
Publication of ATE425459T1 publication Critical patent/ATE425459T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
AT00959706T 1999-08-31 2000-08-31 Der effekt von steroiden auf ndma-rezeptoren beruht auf der zusammensetzung der untereinheiten ATE425459T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15180299P 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
ATE425459T1 true ATE425459T1 (de) 2009-03-15

Family

ID=22540293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00959706T ATE425459T1 (de) 1999-08-31 2000-08-31 Der effekt von steroiden auf ndma-rezeptoren beruht auf der zusammensetzung der untereinheiten

Country Status (7)

Country Link
US (1) US6623933B1 (de)
EP (1) EP1212618B1 (de)
AT (1) ATE425459T1 (de)
AU (1) AU782250B2 (de)
CA (1) CA2383047A1 (de)
DE (1) DE60041773D1 (de)
WO (1) WO2001016601A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1347763A4 (de) * 2000-11-06 2005-10-12 Univ Boston Neuraktive steroidderivate und verfahren zu ihrer verwendung
AUPR731901A0 (en) * 2001-08-28 2001-09-20 Goodchild, Colin Stanley Method of treatment
ES2566765T3 (es) 2010-01-14 2016-04-15 Asarina Pharma Ab Una composición farmacéutica que contiene 3-beta-hidroxi-5-alfa-pregnan-20-ona con propiedades de almacenamiento y solubilidad mejoradas
CZ2014575A3 (cs) * 2014-08-26 2016-02-24 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. Amfifilní sloučeniny s neuroprotektivními účinky
CN108148106A (zh) * 2016-12-05 2018-06-12 江苏恩华络康药物研发有限公司 一类水溶性别孕烯醇酮衍生物及其用途
CN114957445B (zh) * 2022-05-31 2023-09-19 陕西脉元生物科技有限公司 一种nmdar nr1亚基、nmdar的突变体及其构建方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110934A1 (en) 1992-12-11 1994-06-12 Robert L. Foldes Human cns receptors of the nmda-r1 family
AU696922B2 (en) * 1993-04-20 1998-09-24 Merck & Co., Inc. Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
US5888996A (en) 1995-07-26 1999-03-30 Trustees Of Boston University Inhibition of NMDA receptor activity and modulation of glutamate-mediated synaptic activity
EP0840612A1 (de) * 1995-07-24 1998-05-13 Trustees Of Boston University Inhibierung der nmda rezeptoraktivitaet durch pregnolonsulfatderivate
EP1255854A2 (de) * 2000-02-01 2002-11-13 Agy Therapeutics, Inc. Interaktion von nmda rezeptor mit protein tyrosin phosphatase

Also Published As

Publication number Publication date
EP1212618A1 (de) 2002-06-12
DE60041773D1 (de) 2009-04-23
WO2001016601A1 (en) 2001-03-08
US6623933B1 (en) 2003-09-23
CA2383047A1 (en) 2001-03-08
AU782250B2 (en) 2005-07-14
AU7098100A (en) 2001-03-26
EP1212618A4 (de) 2005-04-06
EP1212618B1 (de) 2009-03-11

Similar Documents

Publication Publication Date Title
ATE272841T1 (de) Versuchsanordnung mit erweiterter bandbreite
ATE507524T1 (de) Durchführung von prüfungen an der betriebsmittelbenutzung von computerprogrammen
BR112022003153A2 (pt) Usar um recurso de realimentação configurado para realimentação
AR023402A1 (es) Un aparato y un metodo para recibir y evaluar una solicitud presentada por un solicitante
WO2007038027A3 (en) Methods, systems, and computer program products for verifying an identity of a service requester using presence information
BR0213577A (pt) Método e aparelho de gerenciamento de serviço para manutenção de recursos
BR0316707A (pt) Sistema e método para rastrear reduções de emissão ambiental
ATE551656T1 (de) Verfahren und vorrichtung zum identifizieren von neuem media-inhalt
ATE420504T1 (de) Eingrenzung von netzwerkfehlern
BR9908908A (pt) Sistema e método para aquisição e transmissão remotas de dados
BR0318587A (pt) método e sistema para evitar intrusão em tráfego de comunicação com um conjunto de máquinas em uma rede, rede de telecomunicações, e, produto de programa de computador
ATE433106T1 (de) Bestimmungsmethode fur liganden der nuklearen rezeptoren
BRPI0520469A2 (pt) método e sistema de identificação biométrica automática, e, produto de programa de computador
DE50000288D1 (de) Vorrichtung und verfahren zum verbergen von informationen und vorrichtung und verfahren zum extrahieren von informationen
BR0012964A (pt) Método, sistema e meio de armazenamento passìvel de leitura por computador para configuração de acionador de dispositivo automático
BR0303482A (pt) Aparelho para uso no controle e/ou nos testes de um sistema de produção de hidrocarboneto
ATE426858T1 (de) System und verfahren zum erkennen von bísartigem code
BR112022023129A2 (pt) Seleção de uma instância de aplicação
ATE425459T1 (de) Der effekt von steroiden auf ndma-rezeptoren beruht auf der zusammensetzung der untereinheiten
BR112018075239A2 (pt) agendamento de tarefa ampla de sistema de alerta de travamento de ativação para eficiência energética em dispositivos móveis
NO20055025L (no) Multiplex screening for lysosomale lagringsforstyrrelser (LSD)
FR3094506B1 (fr) Système embarqué à bord d'un aéronef de détection et de réponse aux incidents avec enregistrement de logs
TW200719140A (en) Automatic testing system and method
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
BR9912336A (pt) Processo e sistema para o monitoramento de chamadas telefônicas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties